N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
OA: closed
Abstract
A method of treating cancer such as breast cancer or colon cancer, comprising administer to a non-human patient having cancer a therapeutically effective amount of the compound N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide a method of treating or preventing restenosis in a non-human patient a method of inhibiting the tyrosine phosphorylation of erbB3 in a non-human patient a method of treating psoriasis, atherosclerosis or endometriosis in a non-human patient and a method of inhibiting VEGF secretion in a non-human patient. (62) Divided out of 512189
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-06T06:10:23.601157+00:00